Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus-recent advances.

Karen F Macsween1, Dorothy H Crawford

  • 1University of Edinburgh, Summerhall, Edinburgh, UK.

The Lancet. Infectious Diseases
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two cases of imported respiratory diphtheria in Edinburgh, Scotland, October 2019.

Epidemiology and infection·2020
Same author

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.

British journal of haematology·2014
Same author

Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis.

Archives of neurology·2011
Same author

Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.

Journal of medical virology·2010
Same author

Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up.

Transplantation·2010
Same author

Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2010

Epstein-Barr virus causes lifelong infections and can lead to tumors by evading immune responses. Developing an animal model is crucial for creating effective Epstein-Barr virus vaccines.

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Epstein-Barr virus (EBV) is a common herpes virus causing lifelong latent infections in over 90% of adults.
  • Primary EBV infection in adolescence or adulthood can lead to infectious mononucleosis due to an intense immune response.
  • EBV is tumorigenic, implicated in B lymphoproliferative disease and Hodgkin's disease by influencing B-cell survival.

Purpose of the Study:

  • To understand how Epstein-Barr virus establishes lifelong latent infections.
  • To investigate the mechanisms by which EBV evades immune detection.
  • To identify the need for an animal model for EBV vaccine development.

Main Methods:

  • Analysis of EBV's interaction with B-cell antigen-activation pathways.
  • Study of viral gene expression restriction in memory B lymphocytes.

Related Experiment Videos

  • Investigation of EBV's influence on B-cell survival mechanisms.

    • Main Results:

    • EBV mimics B-cell activation to enter the memory B lymphocyte pool.
    • The virus evades immune elimination by severely restricting its gene expression.
    • EBV influences B-cell survival, potentially inducing tumors.

    Conclusions:

    • Epstein-Barr virus establishes persistent infections by manipulating host cell pathways.
    • Understanding EBV pathogenesis is key to developing preventative and therapeutic vaccines.
    • An animal model is essential for advancing EBV vaccine research and strategy.